| Ytd | -74.48% | |
| 1y | -86.94% |
| Open | 0.15 | Prev Close | 0.15 | Low | 0.11 | High | 0.21 | Mkt Cap | 2.71M |
| Vol | 18.74M | Avg Vol | 258.09K | EPS | -0.11 | P/E | -1.33 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.16 | 200-d Avg | 0.33 | 1yr Est | 0.00 |
Ping An Biomedical Co., Ltd. (NASDAQ:PASW) (hereinafter referred to as "Ping An Biomedical")
HONG KONG, July 22, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (hereinafte
HONG KONG, March 19, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafte
HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter
HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (NASDAQ: PASW) (hereinafte
Hong Kong, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (the “Compa